60
Growth Score
pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
647547
GenPharm International is a develops and commercializes HuMAb-Mouse transgenic animal technology.
David Leathers: Various Roles
Larry Bock: Co-FounderPast Role: Illumina, Co-Founder
Bristol-Myers Squibb
About the Company
GenPharm International, Inc. engages in the development and application of HuMAb-Mouse transgenic animal technology. Its technology is used in the creation of human monoclonal antibodies for therapeutic uses. The company was founded in 1989 and is based in San Jose, California. As of October 21, 1997, GenPharm International, Inc. was a subsidiary
of Medarex, Inc. Later, it operates as a subsidiary of Bristol-Myers Squibb Company.
